Effects of a histamine type 2 receptor antagonist, BMY-26539-01, on equine gastric acid secretion.
A dose-response study was undertaken of the effects of a newly developed histamine type 2 receptor antagonist, BMY-26539-01, on gastric acid secretion in 4 fasted horses. Doses of 0.1 mg/kg, 0.3 mg/kg, 0.5 mg/kg, or placebo were administered in a randomly assigned treatment sequence. Hydrogen ion concentration and pH were variable during baseline measurements in all 4 animals; however, following BMY-26539-01 administration, mean pH increased and hydrogen ion concentration decreased in a dose-related pattern. At the 0.3 mg/kg and 0.5 mg/kg dose levels, pH remained elevated for > 4 h and > 8 h, respectively. No adverse effects were observed. A significant level of 0.01 was used for all statistical methods.
Orsini
J A
JA
Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, New Bolton Center, Kennett Square 19348, USA. orsini@vet.upenn.edu
Spencer
P A
PA
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D005744:Gastric Acid / Q000378:metabolism*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D006736:Horses / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D011970:Receptors, Histamine H2; D013997:Time Factors
D006635:Histamine H2 Antagonists; D011970:Receptors, Histamine H2